GEO Investing

Premium Twitter (x) Alerts

Join us this Thursday at 2 PM EST for a Skull Session Fireside Chat with $CVALF (TSXV:COV), CEO & Director Brent Ashton. hosted by @majgeoinvesting. Interview outline coming tomorrow. Add the event to your calendar, here: https://t.co/6JfQLszFbd
Posted: September 17, 2024
$CANOF new manufacturing facility now ready for production. ICYMI, here is a skull session clip from our conversation with the CEO on this topic. Also makes US$338,335 debt payment. https://t.co/tX6FOprV2C https://t.co/YBzGXGjUyr
Posted: September 17, 2024
$GLGI reports improved EPS on down sales in Q4, management sees robust 2025. https://t.co/5tn80xo4ry https://t.co/7Hm90MnJWm
Posted: September 16, 2024
@badtrader22156 Hey Albert, we closed BOP #11. This is independent of $LFVN. We actually addressed this topic in today’s Weekly Wrap Up :). https://t.co/33e98qpUMq https://t.co/A404MZL7sP
Posted: September 15, 2024
As pondered in a recent weekly & Sept. Open Forum, we’re closing BOP #11. Was a good ride. Closing avg. return of 45.04%, providing large alpha over the indexes. With today’s 10% $LFVN move, 3 of 7 stocks were closed at ~100% or more. See below for index returns over same time?? https://t.co/IWLwak6crq
Posted: September 13, 2024
Transcript of 9 o’clock conference call, where $CPHRF $CPH.TO partner, $MOB.ST, discussed the ramifications of setback in FDA trials concerning its fungus treatment (MLB–015). https://t.co/ol3pizlG3W
Posted: September 13, 2024
RT @GeoPremium: Highlights from my morning email about to be sent out: https://t.co/Bs0ORMjxuB
Posted: September 12, 2024
RT @GeoPremium: Join us today, September 12th at 2 PM EST for a GeoInvesting Skull Session Fireside Chat with President, CEO & Director of…
Posted: September 12, 2024
Join us today, September 12th at 2 PM EST for a GeoInvesting Skull Session Fireside Chat with President, CEO & Director of $LFVN, Steven Fife, hosted by @majgeoinvesting See outline below ?? Join here: https://t.co/7ykNTpP3KT https://t.co/PCcILk6Wzz
Posted: September 12, 2024
Highlights from my morning email about to be sent out: https://t.co/Bs0ORMjxuB
Posted: September 11, 2024

Viewing page 1 of 2|Next Page

GeoWire Weekly

Premium Research

We also wanted to bring to your attention a little news that we alerted via X this morning on California Nanotechnologies Corp. (TSXV:CNO) (CANOF) ($0.81; $36.8M market cap), who just announced a new manufacturing facility and repaid some debt in the amount of US$338,335. “This marks an important milestone in expanding the Company’s manufacturing capabilities and footprint. This expansion…
Posted: September 17, 2024
Greystone Logistic (OOTC:GLGI) ($1.45; $41.0M market cap) – Yesterday we highlighted its Q4 and full year results which showed strong EPS growth on down sales and highlighted comments from the press release where management stated it anticipates “a robust 2025.” We also mentioned: “We are eager to see how fast earnings may be able to accelerate if sales start to increase. We t…
Posted: September 17, 2024
Greystone Logistic (OOTC:GLGI) ($1.34; $37.8M market cap) reported Q4 and full year 2024 results: Q4 sales of $14.8 million vs $16.1 million in the prior year Q4 EPS of $0.04 vs EPS of $0.01 in the prior year Full year sales of $61.7 million vs $60.7 million in the prior year Full year non-GAAP EPS of $0.13 vs non-GAAP EPS of $0.03 Management comments reflect on a successful year, highli…
Posted: September 16, 2024
Transcript: MOB-015 North American Phase 3 Study Results Call (Provided AS IS RAW) Anna Ljung, MOB.ST Thank you, and welcome to this telephone conference following the press release this morning, and this call will be recorded and uploaded on our web page following completion. So with me today, I have our chief medical officer under President and our chief scientific officer, Amir tabakov. An…
Posted: September 13, 2024
CIPHER PHARMACEUTICALS INC (OTC:CPHRF) (TSX:CPH) shares are under pressure today as its licensing partner, Moberg Pharma (MOB.ST) is trading down ~65% as expectations on the primary endpoint for its ongoing phase 3 trail of MOB-015 (topical fungus treatment) are lower than company expectations. Cipher holds exclusive licensing rights to market the fungus treatment in Canada, upon regulatory appro…
Posted: September 13, 2024
Kewaunee Scientific (NASDAQ:KEQU) ($43.06; $122.2M market cap) announced Q1 2025 results: Sales of $48.3 million vs $49.8 million in the prior year EPS of $0.74 vs EPS of $0.19 in the prior year The Company’s order backlog was $159.4 million on July 31, 2024, as compared to $140.8 million on July 31, 2023, and $155.6 million on April 30, 2024. “Our financial performance for the first qua…
Posted: September 12, 2024
Adf Group Inc (OOTC:ADFJF) (TSX:DRX) ($9.70; $291.0M market cap) reported Q2 2024 results: (figures are in CAD) Q2 sales of $74.9 million vs $80.2 million in the prior year Q2 EPS of $0.51 vs $0.32 in the prior year Gross margin, as a percentage of revenues, increased from 22.2% for the 3-month period ended July 31, 2023, to 36.9% for the same period ended July 31, 2024. “Althoug…
Posted: September 12, 2024
Perma-Pipe International Holdin (NASDAQ:PPIH)($11.50; $92M market cap) announced strong Q2 2024 results: Sales of $37.5 million vs $35.1 million in the prior year EPS of $0.40 vs EPS of $0.13 in the prior year “Backlog in the second quarter saw considerable growth and now stands at $75.5 million. This represents a 10% increase from the backlog at January 31, 2024. It should be noted…
Posted: September 11, 2024
Frequency Electronics, Inc. (NASDAQ:FEIM) ($13.73, $131.3 M market cap) announced it’s Q1 2025 financial results. FEIM already resides in our by recently launched Buy on Pullback (BOP) #12 Model Portfolio. Had it not already been in the portfolio, we would be adding it to the portfolio, based on the pullback shares are experiencing this morning. Q1 Results: Sales of $15.0 million vs $1…
Posted: September 11, 2024
Lakeland Industries, Inc. (NASDAQ:LAKE) ($18.85, $139.0M market cap) announced Q2 2025 results: Sales of $38.5 million vs $33.1 million in the prior year and below analyst estimates of $39.9 million. Net loss of $0.19 vs $0.18 in the prior year Non-GAAP EPS of $0.05 vs $0.32 in the prior year and well below analyst estimates of $0.35 “Lakeland delivered second-quarter results below our…
Posted: September 4, 2024

Viewing page 1 of 2|Next Page